Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients

NCT01921296 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Accrual terminated early because of poor accrual

Conditions

Sleep Initiation and Maintenance Disorders
Pain

Interventions

DRUG: Cyclobenzaprine

Sponsor

Lynn Henry

Collaborators

[object Object]